Menu

Blog

Archive for the ‘genetics’ category: Page 456

Jan 19, 2016

A Brief History of Stephen Hawking Being a Bummer

Posted by in categories: engineering, existential risks, genetics, sustainability

Yeah, he’s turned into quite the man-of-panic as of late.


Stephen Hawking is at it again, saying it’s a “near certainty” that a self-inflicted disaster will befall humanity within the next thousand years or so. It’s not the first time the world’s most famous physicist has raised the alarm on the apocalypse, and he’s starting to become a real downer. Here are some of the other times Hawking has said the end is nigh—and why he needs to start changing his message.

Speaking to the Radio Times recently ahead of his BBC Reith Lecture, Hawking said that ongoing developments in science and technology are poised to create “new ways things can go wrong.” The scientist pointed to nuclear war, global warming, and genetically-engineering viruses as some of the most serious culprits.

Continue reading “A Brief History of Stephen Hawking Being a Bummer” »

Jan 18, 2016

Do-It-Yourself Gene-Editing Kit Transforming Biology

Posted by in categories: biotech/medical, genetics

Your own “Do it yourself” gene editing kit for only $120.


To “democratize” science, Josiah Zayner is packaging and selling his DIY gene-editing technique for $120 so that everyone can cut, paste and stir genes as simply as mixing a vodka tonic.

Read more

Jan 18, 2016

Report from Davos: 5 million jobs to be lost by 2020 because of tech advances

Posted by in categories: 3D printing, biotech/medical, economics, employment, genetics, robotics/AI

In less than 4 yrs. 5 million jobs will be lost is the prediction.


A new report predicts a loss of 5 million jobs in the next five years because of technological advances, but don’t blame it all on the robots.

The other culprits: artificial intelligence, 3-D printers and advances in genetics, biotech and more.

Continue reading “Report from Davos: 5 million jobs to be lost by 2020 because of tech advances” »

Jan 17, 2016

DIY gene-editing kit: Is it fun or scary?

Posted by in categories: biotech/medical, ethics, food, genetics, habitats

Although the recent article and announcement of Josiah Zayner (CA scientist) new do it yourself gene editing kit for $120 sent shock waves across industry as well as further raised the question “how do we best put controls in place to ensure ethics and prevent disaster or a crisis?”; this genie truly is out of the bottle. Because Josiah created this easily in his own kitchen, it can be replicated by many others in their own homes. What we have to decide is how to best mitigate it’s impact. Black markets & exotic animal, etc. collectors around the world will pay handsomely for this capability and raise the stakes of the most bizarre animals (deadly and non-deadly) to be created for their own profits and amusements.


BURLINGAME, Calif. — On the kitchen table of his cramped apartment, Josiah Zayner is performing the feat that is transforming biology. In tiny vials, he’s cutting, pasting and stirring genes, as simply as mixing a vodka tonic. Next, he slides his new hybrid creations, living in petri dishes, onto a refrigerator shelf next to the vegetables. And he’s packaging and selling his DIY gene-editing technique for $120 so that everyone else can do it, too.

Read more

Jan 17, 2016

Virgin births: Do we need sex to reproduce?

Posted by in categories: genetics, sex

The article states that European royal houses are all closely related. Well in humanities history it’s thought that over 80% of all marriages were between second cousins or closer. While until the industrial revolution the nobility would have been the only demographic who could travel further than as far as you can walk from your home and back in a day. So until the industrial revolution the nobility were probably the most genetically diverse demographic.


‘Virgin births’ happen in nature more than we thought, says Frank Swain, so what’s stopping human beings from doing the same?

Read more

Jan 16, 2016

Intellia Therapeutics Launches New Division to Accelerate Ex Vivo Programs with CRISPR/Cas9

Posted by in categories: biotech/medical, business, genetics

Excellent news; Intellia to continue their focus of leveraging the CRISPR/Cas9 across a variety of immune cells, such as natural killer cells and T-cells. From my own experiences with T-cells and other blood disorders; this is a big deal and one that I personally excited to see what potential cures and improvements come about.


CAMBRIDGE, Mass.–()–Intellia Therapeutics, a leading gene-editing company, has launched a new division, eXtellia Therapeutics, with the intent of focusing resources and research on ex vivo applications of the novel technology, CRISPR/Cas9. As in vivo and ex vivo programs require different competencies in research, manufacturing and commercialization, eXtellia Therapeutics is being launched to accelerate Intellia’s efforts in areas of significant unmet medical need – immuno-oncology, autoimmune and inflammatory diseases – using an ex vivo approach. Intellia will continue its in vivo programs and strategy through a dedicated scientific team.

“We are excited to announce the establishment of eXtellia, increasing our footprint in ex vivo gene editing for oncology and autoimmune diseases,” said Nessan Bermingham, Ph.D., Chief Executive Officer and Founder, Intellia Therapeutics. “eXtellia enables us to bring together the required capabilities needed to take the CRISPR/Cas9 technology beyond Intellia’s emerging in vivo, HSC and CAR-T efforts. We believe eXtellia further positions us to maximize the CRISPR/ Cas9 opportunity to address severe unmet medical needs for patients.”

Read more

Jan 15, 2016

Genomics, Cannabidiols Drive Epilepsy Research

Posted by in categories: biotech/medical, genetics, neuroscience

This is excellent news for Epilepsy.


Epilepsy, a disorder in which nerve cell activity in the brain is disturbed, causing seizures, is the fourth most common neurological problem, following only migraine, stroke and Alzheimer’s. There is no cure for epilepsy, but there are a variety of treatment options. The disease is estimated to affect 2.2 million people in the U.S., with 150,000 people developing the condition each year.

Personalized medicine Scientists at AES discussed how new technologies, such as gene editing using CRISPR-Cas9, and next-generation sequencing, are empowering them to take a new crack at the human genome and find new ways to diagnose and treat epilepsy.

Continue reading “Genomics, Cannabidiols Drive Epilepsy Research” »

Jan 13, 2016

Why UK researchers hope to try gene-editing on human embryos

Posted by in category: genetics

With a decision imminent on permitting UK gene-editing research using human embryos, New Scientist explains the potential pay-off and limitations of the work.

Read more

Jan 13, 2016

Does our Microbiome Control Us or Do We Control It?

Posted by in categories: biotech/medical, chemistry, food, genetics, health, neuroscience

This is an interesting conjecture.


We may be able to keep our gut in check after all. That’s the tantalizing finding from a new study published today that reveals a way that mice—and potentially humans—can control the makeup and behavior of their gut microbiome. Such a prospect upends the popular notion that the complex ecosystem of germs residing in our guts essentially acts as our puppet master, altering brain biochemistry even as it tends to our immune system, wards off infection and helps us break down our supersized burger and fries.

In a series of elaborate experiments researchers from Harvard Medical School and Brigham and Women’s Hospital discovered that mouse poop is chock full of tiny, noncoding RNAs called microRNAs from their gastrointestinal (GI) tracts and that these biomolecules appear to shape and regulate the microbiome. “We’ve known about how microbes can influence your health for a few years now and in a way we’ve always suspected it’s a two-way process, but never really pinned it down that well,” says Tim Spector, a professor of genetic epidemiology at King’s College London, not involved with the new study. “This [new work] explains quite nicely the two-way interaction between microbes and us, and it shows the relationship going the other way—which is fascinating,” says Spector, author of The Diet Myth: Why the Secret to Health and Weight Loss Is Already in Your Gut.

Continue reading “Does our Microbiome Control Us or Do We Control It?” »

Jan 11, 2016

Illumina Launches GRAIL, Focused on Blood-Based Cancer Screening

Posted by in categories: biotech/medical, genetics

Early detection by Grail (leveraging illumina’s gene sequencing technology) looks promising. This truly will be beneficial for early detection. And, I will be very interested in seeing how it benefits those who are genetically pre-disposed to cancer related gene mutations especially around Esaphogus, Glioblastoma, and Pancreatic cancers since these are often hard to detect in their earliest stages.

Read more